admin September 4, 2017

Glioblastoma, an aggressive primary brain tumor, is among the most lethal of human cancers. We present evidence of the potential therapeutic benefit of adoptive T-cell therapy against glioblastoma with the use of CAR-engineered T cells targeting IL13Rα2, a glioma-associated antigen linked to a…

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...